1. A study on pharmacokinetics, pharmacodynamics and safety of lixisenatide in children and adolescents with type 2 diabetes
   Margarita Barrientos‐Pérez et al, 2022, Pediatric Diabetes CrossRef
2. Pharmacological Treatment in Diabetes Mellitus Type 1 – Insulin and What Else?
   Ewa Otto-Buczkowska et al, 2017, International Journal of Endocrinology and Metabolism CrossRef
3. Brain signalling systems: A target for treating type I diabetes mellitus
   R. Ramakrishnan, 2019, Brain Research Bulletin CrossRef
4. Sumoylation Modulates the Susceptibility to Type 1 Diabetes
   Jing Zhang et al, 2017, SUMO Regulation of Cellular Processes CrossRef
5. Recent developments in pediatric and geriatric dosage forms
   ALSayyed A.N. Sallam et al, 2024, Novel Formulations and Future Trends CrossRef
6. Comparison of pharmacokinetics and the exposure–response relationship of dapagliflozin between adolescent/young adult and adult patients with type 1 diabetes mellitus
   David Busse et al, 2019, British Journal of Clinical Pharmacology CrossRef
7. Introduction
   C. Hizel et al, 2017, Progress and Challenges in Precision Medicine CrossRef
8. Novel blood glucose lowering therapies for managing type 1 diabetes in paediatric patients
   Anda Mihaela Naciu et al, 2018, Expert Opinion on Pharmacotherapy CrossRef
9. The effect of metformin on vitamin B12 level in pediatric patients
   Y. Miles Yu et al, 2022, Annals of Pediatric Endocrinology & Metabolism CrossRef